The revenue miss and decelerating growth temper the EPS beat and guidance raise. Watch for execution on the OneOncology integration and the MWI/Covetrus merger to drive margin expansion in H2. The $1B buyback signals management confidence but is not a catalyst on its own given slowing top-line momentum.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 6 $252.74entry
- T+1 · 6mo ago +1.16%α +1.49% · $255.66
- T+5 · 6mo ago +3.24%α +2.11% · $260.93
- T+20 · 6mo ago +4.31%α +1.53% · $263.64
- T+60 · 4mo ago +23.19%α +21.12% · $311.34
Price Chart
How similar events traded
Executive Summary
Cencora reported fiscal Q2 2026 adjusted diluted EPS of $4.75, slightly above the $4.73 consensus estimate, on revenue of $78.4B (below the $81.04B consensus). The company raised its full-year adjusted EPS guidance range to $17.65-$17.90 from $17.45-$17.75 and announced a $1B share repurchase plan. However, revenue growth decelerated to 3.8% YoY (vs 5.5% in Q1), and adjusted operating income growth slowed to 6.0% (vs 11.9% in Q1), signaling maturing momentum in the core distribution business.
Key Financial Metrics
Key Facts
- Adjusted diluted EPS of $4.75 vs consensus $4.73 (beat by 0.4%)
- Revenue of $78.4B vs consensus $81.04B (miss by 3.3%)
- Revenue growth slowed to 3.8% YoY from 5.5% in Q1
- Adjusted operating income growth slowed to 6.0% from 11.9% in Q1
- Full-year adjusted EPS guidance raised to $17.65-$17.90 from $17.45-$17.75
- Company expects to repurchase $1B in shares by end of calendar 2026
- Quarterly dividend maintained at $0.60 per share
- Completed acquisition of OneOncology in February 2026
- Signed definitive agreement to merge MWI Animal Health with Covetrus
- Signed definitive agreement to acquire EyeSouth Partners retina business
Financial Impact
Adjusted EPS beat by $0.02 (0.4%); revenue miss of ~$2.6B (3.3%); guidance raised by $0.15-$0.20 at midpoint
Risk Factors
- Revenue growth deceleration to 3.8% from 5.5% signals maturing core distribution business
- Revenue miss of 3.3% vs consensus may pressure the stock near-term
- Interest expense increased 35.1% YoY due to debt-financed acquisitions
- Operating cash flow negative $966.5M in H1 due to working capital needs
- International segment operating income declined 0.6% on a six-month basis
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140859-26-000018 |
| Document: abc-20260506.htm | 0001140859-26-000018 |
| Document: 0001140859-26-000018-index-headers.html | 0001140859-26-000018 |
| Document: 0001140859-26-000018-index.html | 0001140859-26-000018 |
| Document: 0001140859-26-000018.txt | 0001140859-26-000018 |
| 8-K Data (Synthetic) | 0001140859-26-000018 |
Track record
12 reports on COR
1 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +6.03% at T+20 after the Aug 5, 2026 report. 1 of 4 went positive at some point.
Filters
- Nov 4, 202612d ago 8-K Neutral 2/10 Entry $354.00 to $339.68 Now $359.03 +1.42% ▼ −4.05% +0.36% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $354.00 to $339.68 Now $359.03 +1.42% ▼ −4.05% +0.36% vs SPY
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $340.43 to $338.48 Now $359.03 +5.46% ▼ −0.57% +0.61% vs SPY
- Oct 20, 202627d ago Institutional Cluster Mixed 3/10 Entry $340.43 to $338.48 Now $359.03 +5.46% ▼ −0.57% +0.61% vs SPY
- Sep 25, 20267w ago 8-K Neutral 2/10 Entry $306.92 to $303.81 Now $359.03 +16.98% ▼ −1.01% −0.27% vs SPY
- Aug 21, 202612w ago Institutional Cluster Mixed 6/10 Entry $318.04 to $323.77 Now $359.03 +12.89% ▲ +1.80% +2.10% vs SPY
- Aug 5, 202614w ago 8-K Neutral 3/10 Entry $317.22 to $325.01 Now $359.03 +13.18% ▲ +2.46% +2.62% vs SPY
- Aug 5, 202614w ago 8-K Bullish 6/10 Entry $317.22 to $325.01 Now $359.03 +13.18% ▲ +2.46% +2.62% vs SPY
- Jun 15, 202622w ago 8-K Neutral 2/10 Entry $281.46 to $277.09 Now $359.03 +27.56% ▼ −1.55% −0.30% vs SPY
- May 29, 202624w ago 8-K Neutral 3/10 Entry $264.69 to $264.84 Now $359.03 +35.64% ▲ +0.06% −0.10% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers